Estrogen disrupts chemokine-mediated chemokine release from mammary cells: Implications for the interplay between estrogen and IP-10 in the regulation of mammary tumor formation

Breast Cancer Research and Treatment

Volumn 84, Issue 3, 2004, Pages 235-245

  Aronica, S M ^a   Fanti, P ^a   Kaminskaya, K ^a   Gibbs, K ^a   Raiber, L ^a   Nazareth, M ^a   Bucelli, R ^a   Mineo, M ^a   Grzybek, K ^a   Kumin, M ^a   Poppenberg, K ^a   Schwach, C ^a   Janis, K ^a  

^a CANISIUS COLLEGE   (United States)

Author keywords

Chemokine; Chemokine receptor; Estrogen; Mammary; Mammary tumor

Indexed keywords

4 HYDROXYTAMOXIFEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; ESTROGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CELL; CANCER RISK; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INFLAMMATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; CELL CULTURE TECHNIQUES; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES, CXC; CYTOKINES; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; MAMMARY GLANDS, ANIMAL; MICE; RECEPTORS, CHEMOKINE; RISK FACTORS;

EID: 11144358612     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000019961.59306.f6     Document Type: Article

References (41)

1. Zumoff B: Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy. Proc Soc Exp Biol Med 217: 30-37, 1998
2. Couse JF, Korach KS: Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20: 358-417, 1999
3. Olsen NJ, Kovacs WJ: Gonadal steroids and immunity. Endocr Rev 17: 369-384, 1996
4. Shevde NK, Pike JW: Estrogen modulates the recruitment of myeolpoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis. Blood 87: 2683-2692, 1996
5. Jilka RL, Passeri G, Girasole G, Cooper S, Abrams J, Broxmeyer H, Manolagas SC: Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6. Exp Hematol 23: 500-506, 1995
6. Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD: Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 38: 46-54, 1997
7. Dayan M, Zinger H, Kalush F, Mor G, Amir-Zaltzman Y, Kohen F, Sthoeger Z, Mozes E: The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology 90: 101-108, 1997
8. Curfs JHAJ, Meis JFGM, Hoogkamp-Korstanje JAA: A primer on cytokines: sources, receptors, effects and inducers. Clin Microbiol Rev 10: 742-780, 1997
9. Borish LC, Steinke JW: 2. Cytokines and chemokines. J Allergy Clin Immunol 111: S460-S475, 2003
10. D' Ambrosio D, Panina-Bordignon P, Sinigaglia F: Chemokine receptors in inflammation: an overview. J Immunol Methods 273: 3-13, 2003
11. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001
12. Yu JL, Rak JW: Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res 5: 83-88, 2003
13. Speirs V, Green AR, Atkin SL: Activity and gene expression of 17β-hydroxysteroid dehydrogenase Type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8. J Steriod Biochem Mol Biol 67: 267-274, 1998
14. Aronica SM, Katzenellenbogen BS: Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol 7: 743-752, 1993
15. Stewart CC, Stewart SJ: Cell preparation for the identification of leukocytes. In: Danzunkiewicz Z, Crissman H, Robinson JP (eds) Methods of Cell Biology. Vol 64, Chapter 11, Academic Press, New York, 2001
16. Karpuzoglu-Sahin E, Hissong BD, Ansar-Ahmed S: Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol. J Reprod Immunol 52: 113-127, 2001
17. Murdoch C, Finn A: Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043, 2000
18. Cnristopherson 2nd K, Hromas R: Chemokine regulation of normal and pathologic immune responses. Stem Cells 19: 388-396, 2001
19. Helbig G, Christopherson 2nd KW, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE, Nakshatri H: NF-{kappa}B promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638, 2003
20. Lu B, Humbles A, Bota D, Gerard C, Moser B, Soler D, Luster AD, Gerard NP: Structure and function of the murine chemokine receptor CXCR3. Eur J Immunol 29: 3804-3812, 1999
21. Janis K, Hoeltke J, Nazareth M, Fanti P, Poppenberg K, Aronica SM: Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes. Am J Reprod Immunol 50, 2003 (in press).
22. Oh JW, Drabik K, Kutsch O, Choi C, Tousson A, Benveniste EN: CXC chemokine receptor 4 expression and function in human astroglioma cells. J Immunol 166: 2695-2704, 2001
23. Rodriguez E, Lopez R, Paez A, Masso F, Montano LF: 17Beta-estradiol inhibits the adhesion of leukocytes in TNF-alpha stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sci 71: 2181-2193, 2002
24. Bochner BS: Road signs guiding leukocytes along the inflammation superhighway. J Allergy Clin Immunol 106: 817-828, 2000
25. Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K, Toi M: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92: 1085-1091, 2001
26. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Stricter RM: CXC chemokines in angiogenesis. J Leukoc Biol 68: 1-8, 2000
27. Szekanecz Z, Koch AE: Chemokines and angiogenesis. Curr Opin Rheumatol 13: 202-208, 2001
28. Arenberg DA, White ES, Burdick MD, Strom SR, Stricter RM: Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10). Cancer Immunol Immunother 50: 533-538, 2001
29. Palmer K, Hitt M, Emtage PC, Gyorffy S, Gauldie J: Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. Gene Ther 8: 282-290, 2001
30. Dorsey R, Kundu N, Yang Q, Tannenbaum CS, Sun H, Hamilton TA, Fulton AM: Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Cancer Res 62: 2606-2610, 2002
31. Fanti P, Nazareth M, Bucelli R, Mineo M, Gibbs K, Kumin M, Grzybek K, Poppenberg K, Janis K, Schwach C, Aronica SM: Estrogen decreases chemokine levels in murine mammary tissue: implications for the regulatory role of MIP-1 alpha and MCP-1/JE in mammary tumor formation. Endocrine 22, 2003 (in press)
32. Neumark E, Sagi-Assif O, Shalmon B, Ben-Baruch A, Witz IP: Progression of mouse mammary tumors: MCP-1-TNF alpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors. Int J Cancer 106: 879-886, 2003
33. Castagnetta L, Cotolo M, Granata OM, Di Falco M, Bellavia V, Carruba G: Endocrine end-points in rheumatoid arthritis. Ann NY Acad Sci 876: 180-191, 1999
34. Martin TJ: Sexual dimorphism in immune function: the role of prenatal exposure to androgens and estrogens. Eur J Pharmacol 405: 251-261, 2000
35. Novotny L, Rauko P, Vachalkova A, Peterson-Biggs M: Tamoxifen in cancer therapy. Neoplasma 47: 3-7, 2000
36. Inadera H, Sekiya T, Yoshimura T, Matsushima K: Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology 141: 50-59, 2000
37. McDonnell DP, Connor CE, Wijayaratne A, Chang CY, Norris JD: Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog Horm Res 57: 295-316, 2002
38. Graham JD, Bain DL, Richer JK, Jackson TA, Tung L, Horwitz KB: Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer. Steroids 65: 579-584, 2000
39. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61: 246-257, 1997
40. Jordan VC, Gapstur S, Morrow M: Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 93: 1449-1457, 2001
41. Bachelder RE, Wendt MA, Mercurio AM: Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206, 2002